Showing results (1631-1640 of 8,017) with videos related to
Sort By:
Pageof 802
Current Medicinal Chemistry|September 6, 2018
Targeting Long Non-Coding RNAs in Nervous System Cancers: New Insights in Prognosis, Diagnosis and TherapyNikos Malissovas, Elpinickie Ninou, Artemis Michail, et al.Current Medicinal Chemistry|September 6, 2018
The Current Status and Perspectives of Delivery Strategy for Boronbased DrugsZhu Yinghuai, Xinglong Lin, Hongming Xie, et al.Current Medicinal Chemistry|February 17, 2010
The role of oligodendrocytes in the molecular pathobiology and potential molecular treatment of cervical spondylotic myelopathyS K Karadimas, C H Gialeli, G Klironomos, et al.Current Medicinal Chemistry|February 17, 2010
Dehydroepiandrosterone (DHEA): a steroid with multiple effects. Is there any possible option in the treatment of critical illness?R Oberbeck, P KobbeCurrent Medicinal Chemistry|February 17, 2010
Organotypic cultures as tool to test long-term effects of chemicals on the nervous systemF PeñaCurrent Medicinal Chemistry|February 17, 2010
Inhibitors of the mitochondrial electron transport chain and de novo pyrimidine biosynthesis as antimalarials: The present statusT Rodrigues, F Lopes, R MoreiraCurrent Medicinal Chemistry|February 20, 2010
From surface to nuclear receptors: the endocannabinoid family extends its assetsM Pistis, M MelisCurrent Medicinal Chemistry|February 20, 2010
Novel natural and synthetic ligands of the endocannabinoid systemLumír O Hanus, Raphael MechoulamCurrent Medicinal Chemistry|February 20, 2010
Recent advances in anti-survivin treatments for cancerR K Kanwar, C H A Cheung, J-Y Chang, et al.Current Medicinal Chemistry|February 20, 2010
New opportunities to treat the T315I-Bcr-Abl mutant in chronic myeloid leukaemia: tyrosine kinase inhibitors and molecules that act by alternative mechanismsS Schenone, C Brullo, M BottaPageof 802